Bristol Myers Squibb (BMY) Stock Valuation: P/E Ratio and Intrinsic Value

Is Bristol Myers Squibb stock expensive or cheap? This page shows the price-earnings ratio of Bristol Myers Squibb for the last fiscal years, the current share price, and beta and volatility as risk measures. Earnings figures come from the company's published filings.

How the Bristol Myers Squibb P/E ratio is calculated

The price-earnings ratio divides the share price by earnings per share. On this page the ratio is shown per fiscal year, so you can see whether today's valuation of Bristol Myers Squibb is above or below its own history. Beta and volatility indicate how strongly the share moves compared with the overall market.

Frequently asked questions about Bristol Myers Squibb

What is the BMY P/E ratio?

The P/E ratio divides the Bristol Myers Squibb share price by earnings per share. This page shows the ratio for each of the last fiscal years, so the current valuation of BMY can be compared with its own history.

Is Bristol Myers Squibb stock overvalued or undervalued?

There is no single answer. A useful check is whether the current P/E of BMY is above or below its multi-year average and how earnings, margins and revenue are developing. This page shows all of these figures from the published filings.

How can I estimate the intrinsic value of Bristol Myers Squibb?

An intrinsic value estimate needs earnings or free cash flow, a growth assumption and a discount rate. This page provides the reported earnings basis, margins and the valuation history of BMY as the starting point.

More on Bristol Myers Squibb

• Bristol Myers Squibb stock: revenue, segments and business model
• Bristol Myers Squibb quarterly earnings